Alaunos Therapeutics Inc (TCRT)

Jul 02, 2026

Form 4 Alaunos Therapeutics Inc For: 2 July By Investing.com - Investing.com Canada

Jul 02, 2026

Jul 02, 2026

Stock grant to Alaunos (TCRT) CEO issued in lieu of salary - Stock Titan

Jul 02, 2026

Jun 29, 2026

Alaunos Reports New Preclinical ALN1003 Data Showing Lower Liver Weight After Adjustment for Body Fat Percentage in 48-Day DIO Mouse Study - markets.businessinsider.com

Jun 29, 2026

Jun 29, 2026

Alaunos Reports New Preclinical Liver Data for ALN1003 - TipRanks

Jun 29, 2026

Jun 29, 2026

Alaunos Therapeutics (TCRT) posts new ALN1003 mouse liver and metabolic findings - Stock Titan

Jun 29, 2026

Jun 29, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga

Jun 29, 2026

Jun 26, 2026

Alaunos Therapeutics, Inc. Actuals & Estimates (NASDAQ:TCRT) - TradingView

Jun 26, 2026

Jun 24, 2026

Alaunos Therapeutics Inc (TCRT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 24, 2026

Jun 19, 2026

Alaunos Therapeutics Inc (TCRT) Institutional Confidence - TradingKey

Jun 19, 2026

Jun 18, 2026

Alaunos Therapeutics Inc (TCRT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026

Jun 17, 2026

Alaunos Therapeutics Inc (TCRT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

Alaunos Therapeutics Inc (TCRT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

Alaunos Therapeutics (TCRT) CEO takes 7,761-share stock grant in lieu of salary - Stock Titan

Jun 17, 2026

Jun 17, 2026

Alaunos Therapeutics Inc (TCRT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026

Jun 16, 2026

Alaunos Therapeutics Inc (TCRT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 16, 2026

Jun 16, 2026

Alaunos Therapeutics Inc (TCRT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 16, 2026

Jun 15, 2026

TCRT Q4 2023 Earnings: EPS Miss Amid Ongoing Clinical DevelopmentEarnings Surprise Report - newsline.com

Jun 15, 2026

Jun 14, 2026

Alaunos Therapeutics Reports Encouraging Early Obesity Drug Results - Stocktwits

Jun 14, 2026

Jun 12, 2026

Number of shareholders of Alaunos Therapeutics, Inc. – NASDAQ:TCRT - TradingView

Jun 12, 2026

Jun 09, 2026

TCRT Q4 2023 Earnings: EPS Misses Estimates, No Revenue Reported, Stock DeclinesEarnings Stability Report - newsline.com

Jun 09, 2026

Jun 07, 2026

Alaunos Therapeutics (TCRT) Declines 6.56% as Stock Tests Key Support Near $2.17Swing Trade Setups - newsline.com

Jun 07, 2026

Jun 06, 2026

TCRT Q4 2023 Earnings: Wider-Than-Expected Loss on Lack of RevenueROE Trend Analysis - newsline.com

Jun 06, 2026

Jun 05, 2026

Alaunos Therapeutics (TCRT) falls on cash concerns, Nasdaq delisting risk - Bez Kabli

Jun 05, 2026

Jun 04, 2026

Eli Lilly continues genetic medicine push with $1.9bn Ascidian partnership - Pharmaceutical Technology

Jun 04, 2026

Jun 02, 2026

Alaunos Therapeutics (TCRT) Declines 4.18% as Biotech Sector Pressure Tests Key Support LevelsQuality ETF - newsline.com

Jun 02, 2026

May 31, 2026

Alaunos Therapeutics Q4 2023 Earnings: EPS Miss Widens as Pre-Revenue Biotech Faces Continued HeadwindsDebt Analysis Report - newsline.com

May 31, 2026

May 29, 2026

Alaunos Therapeutics (TCRT) Dips 6.86% as Stock Approaches Critical Support LevelChaikin Flow - The Legal Advocate

May 29, 2026

May 29, 2026

TCRT Q4 2023 Earnings: Wider-Than-Expected Loss as Pre-Revenue Biotech Advances PipelineEarnings Season Outlook - newsline.com

May 29, 2026

May 27, 2026

Alaunos Therapeutics (TCRT) CEO takes 3,700 shares instead of salary - Stock Titan

May 27, 2026

May 27, 2026

Alaunos reports positive preclinical obesity drug results across weight, liver, insulin markers - MSN

May 27, 2026

May 26, 2026

Alaunos Therapeutics (TCRT) Drops 2.69% as Support Level Holds SteadyDip Buy Trade - The Legal Advocate

May 26, 2026

May 26, 2026

Alaunos Reports Positive Preclinical Metabolic Data for ALN1003 - TipRanks

May 26, 2026

May 26, 2026

Alaunos reports preclinical data for obesity drug candidate ALN1003 - Investing.com UK

May 26, 2026

May 26, 2026

Alaunos reports preclinical data for obesity drug candidate ALN1003 By Investing.com - Investing.com South Africa

May 26, 2026

May 26, 2026

TCRTAlaunos Therapeutics Inc Stock Price and Quote - Finviz

May 26, 2026

May 26, 2026

Alaunos Therapeutics Reports Positive Preclinical Results for ALN1003 in Addressing Metabolic Disease Markers - Quiver Quantitative

May 26, 2026

May 26, 2026

ALN1003 obesity data and cash runway update from Alaunos (NASDAQ: TCRT) - Stock Titan

May 26, 2026

May 23, 2026

TCRT Q4 2023 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Reports No RevenueGuidance Update - Newser

May 23, 2026

May 21, 2026

Alaunos Therapeutics (TCRT) Q4 2023 Earnings Fall Short: EPS $-4.90 Misses MarkBuyback Announcement Report - Newser

May 21, 2026

May 19, 2026

Alaunos Therapeutics Announces Promising Preclinical Results for ALN1003 in Metabolic Syndrome and Obesity Models - Minichart

May 19, 2026

May 18, 2026

Alaunos Therapeutics (TCRT) Reveals Promising Preclinical Data f - GuruFocus

May 18, 2026

May 18, 2026

Alaunos Therapeutics, Inc.Common Stock (Nasdaq:TCRT) Stock Quote - FinancialContent

May 18, 2026

May 18, 2026

Alaunos reports preclinical data for obesity drug candidate - Investing.com UK

May 18, 2026